Callan Family Office’s Freeport-McMoran FCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Buy
41,879
+3,954
+10% +$254K 0.05% 317
2026
Q1
$2.23M Buy
37,925
+1,031
+3% +$62.3K 0.05% 326
2025
Q4
$1.87M Buy
36,894
+12,827
+53% +$556K 0.04% 370
2025
Q3
$944K Sell
24,067
-2,916
-11% -$126K 0.03% 390
2025
Q2
$1.17M Buy
26,983
+18,803
+230% +$714K 0.04% 367
2025
Q1
$310K Sell
8,180
-5,029
-38% -$192K 0.02% 416
2024
Q4
$503K Buy
+13,209
New +$591K 0.03% 366

Other funds holding FCX

Callan Family Office's FCX Position: Q2 2026 in Review

Callan Family Office increased its Freeport-McMoran (FCX) stake by 10% in Q2 2026, buying an estimated $254K and bringing the position to 41,879 shares worth $2.63M. The position accounts for 0.05% of the portfolio, ranked #317.

Callan Family Office first reported a position in FCX in Q4 2024 and has held it in 7 quarters since. 1,888 funds tracked by Wall St. Rank hold FCX as of Q2 2026.

  • Callan Family Office held 41,879 shares of Freeport-McMoran worth $2.63M as of Q2 2026.
  • Callan Family Office bought 3,954 Freeport-McMoran shares in Q2 2026, an estimated $254K.
  • Freeport-McMoran made up 0.05% of Callan Family Office's portfolio in Q2 2026, its #317 holding.
  • Callan Family Office first reported a position in Freeport-McMoran in Q4 2024 and has held it in 7 quarters since.
  • 1,888 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.